Epoch Biodesign

About

Epoch Biodesign is a biodesign company focused on developing AI-designed enzymes for circular recycling of plastics and textiles. By integrating synthetic biology, artificial intelligence, and materials science, Epoch aims to create sustainable alternatives to traditional recycling methods. Their mission is to transform the recycling system into a circular economy, significantly increasing the recycling rate from one percent towards one hundred percent. The company has developed a proprietary platform that utilizes generative AI and physics-based data modeling to engineer enzymes that can break down complex materials. Their biorecycling solutions target nylon, polyester, and mixed plastics, converting them into industrial chemicals for various applications, including adhesives and fertilizers. Epoch's process operates at low temperatures with environmentally friendly enzymes, making it cost-competitive with fossil-based materials. Currently, Epoch is in a growth phase, having recently launched the UK's first biorecycling facility and expanded its team. Their headquarters in London features a specialized lab-enabled workspace, supporting their commitment to providing sustainable solutions for industries such as apparel, automotive, and packaging.